These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35259278)

  • 21. Safety and Efficacy of Allogeneic Umbilical Cord Blood Therapy for Global Development Delay and Intellectual Disability.
    Cha B; Kwak H; Bang JI; Jang SJ; Suh MR; Choi JI; Kim M
    Stem Cells Dev; 2023 Apr; 32(7-8):170-179. PubMed ID: 36734415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late vs early clamping of the umbilical cord in full-term neonates: systematic review and meta-analysis of controlled trials.
    Hutton EK; Hassan ES
    JAMA; 2007 Mar; 297(11):1241-52. PubMed ID: 17374818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethical issues in umbilical cord blood banking. Working Group on Ethical Issues in Umbilical Cord Blood Banking.
    Sugarman J; Kaalund V; Kodish E; Marshall MF; Reisner EG; Wilfond BS; Wolpe PR
    JAMA; 1997 Sep; 278(11):938-43. PubMed ID: 9302248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Could cord blood cell therapy reduce preterm brain injury?
    Li J; McDonald CA; Fahey MC; Jenkin G; Miller SL
    Front Neurol; 2014; 5():200. PubMed ID: 25346720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal sex and weight influence CD34(+) cell concentration in umbilical cord blood but not stromal cell-derived factor 1-3'A polymorphism.
    Bijou F; Ivanovic Z; Fizet D; Dazey B; Boiron JM; Lafarge X
    Cytotherapy; 2015 Jan; 17(1):68-72. PubMed ID: 25446160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Umbilical cord blood stem cell therapy in premature brain injury: Opportunities and challenges.
    Peng X; Song J; Li B; Zhu C; Wang X
    J Neurosci Res; 2020 May; 98(5):815-825. PubMed ID: 31797400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes.
    Rabe H; Diaz-Rossello JL; Duley L; Dowswell T
    Cochrane Database Syst Rev; 2012 Aug; (8):CD003248. PubMed ID: 22895933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of umbilical cord milking at birth: a systematic review and meta-analysis.
    Al-Wassia H; Shah PS
    JAMA Pediatr; 2015 Jan; 169(1):18-25. PubMed ID: 25365246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic human umbilical cord-derived mesenchymal stem/stromal cells for chronic obstructive pulmonary disease (COPD): study protocol for a matched case-control, phase I/II trial.
    Hoang DM; Nguyen KT; Nguyen AH; Nguyen BN; Nguyen LT
    BMJ Open; 2021 May; 11(5):e045788. PubMed ID: 33986057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
    Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
    Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous Umbilical Cord Blood-Derived Mononuclear Cell Therapy Promotes Cardiac Proliferation and Adaptation in a Porcine Model of Right Ventricle Pressure Overload.
    Oommen S; Cantero Peral S; Qureshi MY; Holst KA; Burkhart HM; Hathcock MA; Kremers WK; Brandt EB; Larsen BT; Dearani JA; Edwards BS; Maleszewski JJ; Nelson TJ;
    Cell Transplant; 2022; 31():9636897221120434. PubMed ID: 36086821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous umbilical cord blood infusion for type 1 diabetes.
    Haller MJ; Viener HL; Wasserfall C; Brusko T; Atkinson MA; Schatz DA
    Exp Hematol; 2008 Jun; 36(6):710-5. PubMed ID: 18358588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteogenic potential of human umbilical cord-derived mesenchymal stromal cells cultured with umbilical cord blood-derived fibrin: a preliminary study.
    Baba K; Yamazaki Y; Ishiguro M; Kumazawa K; Aoyagi K; Ikemoto S; Takeda A; Uchinuma E
    J Craniomaxillofac Surg; 2013 Dec; 41(8):775-82. PubMed ID: 23465638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of cord blood for transfusion purposes: current status.
    Khodabux CM; Brand A
    Vox Sang; 2009 Nov; 97(4):281-93. PubMed ID: 19570065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.
    Friedman R; Betancur M; Boissel L; Tuncer H; Cetrulo C; Klingemann H
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1477-86. PubMed ID: 18022578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34
    Bucar S; Branco ADM; Mata MF; Milhano JC; Caramalho Í; Cabral JMS; Fernandes-Platzgummer A; da Silva CL
    Stem Cell Res Ther; 2021 Jul; 12(1):399. PubMed ID: 34256848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-Based Therapy Using Umbilical Cord Blood for Novel Indications in Regenerative Therapy and Immune Modulation: An Updated Systematic Scoping Review of the Literature.
    Rizk M; Aziz J; Shorr R; Allan DS
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1607-1613. PubMed ID: 28602892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of umbilical cord blood for stem cell research.
    Bordet S; Nguyen TM; Knoppers BM; Isasi R
    J Obstet Gynaecol Can; 2010 Jan; 32(1):58-61. PubMed ID: 20370983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous injection of umbilical cord-derived mesenchymal stromal cells attenuates reactive gliosis and hypomyelination in a neonatal intraventricular hemorrhage model.
    Mukai T; Mori Y; Shimazu T; Takahashi A; Tsunoda H; Yamaguchi S; Kiryu S; Tojo A; Nagamura-Inoue T
    Neuroscience; 2017 Jul; 355():175-187. PubMed ID: 28504197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colony Forming Potential and Protein Composition of Commercial Umbilical Cord Allograft Products in Comparison With Autologous Orthobiologics.
    Berger DR; Centeno CJ; Kisiday JD; McIlwraith CW; Steinmetz NJ
    Am J Sports Med; 2021 Oct; 49(12):3404-3413. PubMed ID: 34398643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.